Open AccessContrast‐enhanced computed tomography with myocardial three‐dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy
Author(s) -
Hamatani Yasuhiro,
Amaki Makoto,
Kanzaki Hideaki,
Yamashita Kizuku,
Nakashima Yasuteru,
Shibata Atsushi,
Okada Atsushi,
Takahama Hiroyuki,
Hasegawa Takuya,
Shimahara Yusuke,
Sugano Yasuo,
Fujita Tomoyuki,
Shiraishi Isao,
Yasuda Satoshi,
Kobayashi Junjiro,
Anzai Toshihisa
Publication year - 2017
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.12178
Subject(s) - medicine , percutaneous , alcohol septal ablation , intracardiac injection , refractory (planetary science) , cardiology , ablation , hypertrophic cardiomyopathy , computed tomography , obstructive cardiomyopathy , radiology , ventricular outflow tract obstruction , cardiomyopathy , heart failure , physics , astrobiology
Both surgical myectomy and percutaneous transluminal septal myocardial ablation are effective treatments for drug‐refractory symptomatic hypertrophic obstructive cardiomyopathy (HOCM). However, in some cases, it is not easy to elucidate the abnormal structure of left ventricular outflow obstruction to adopt these treatments. Here, we presented a young female patient with drug‐refractory symptomatic HOCM. In this case, contrast‐enhanced computed tomography enabled us to assess the suitability of percutaneous transluminal septal myocardial ablation. By creating three‐dimensional printed models using computed tomography data, we could also visualize intracardiac structure and simulate the surgical procedure. A multimodality assessment strategy is useful for evaluating patients complicated with drug‐refractory symptomatic HOCM.